MD. Health - General Code Ann. §  13-111 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 1 - Hereditary and Congenital Disorders Programs|Section 13-111 - Statewide System for Screening Newborns

    (a)    The Department shall establish a coordinated statewide system for screening all newborn infants in the State for certain hereditary and congenital disorders associated with severe problems of health or development, except when the parent or guardian of the newborn infant objects.    (b)    Except as provided in § 13–112 of this subtitle, the Department’s public health laboratory is the sole laboratory authorized to perform tests on specimens from newborn infants collected to screen for hereditary and congenital disorders as determined under subsection (d)(2) of this section.    (c)    The system for newborn screening shall include:        (1)    Laboratory testing and the reporting of test results; and        (2)    Follow–up activities to facilitate the rapid identification and treatment of an affected child.    (d)    In consultation with the State Advisory Council on Hereditary and Congenital Disorders, the Department shall:        (1)    Establish protocols for a health care provider to obtain and deliver test specimens to the Department’s public health laboratory;        (2)    Determine the screening tests that the Department’s public health laboratory is required to perform;        (3)    Maintain a coordinated statewide system for newborn screening that carries out the purpose described in subsection (c) of this section that includes:            (i)    Communicating the results of screening tests to the health care provider of the newborn infant;            (ii)    Locating newborn infants with abnormal test results;            (iii)    Sharing newborn screening information between hospitals, health care providers, treatment centers, and laboratory personnel;            (iv)    Delivering needed clinical, diagnostic, and treatment information to health care providers, parents, and caregivers; and            (v)    Notifying parents and guardians of newborn infants that laboratories other than the Department’s public health laboratory are authorized to perform postscreening confirmatory or diagnostic tests on newborn infants for hereditary and congenital disorders; and        (4)    Adopt regulations that set forth the standards and requirements for newborn screening for hereditary and congenital disorders that are required under this subtitle, including:            (i)    Performing newborn screening tests;            (ii)    Coordinating the reporting, follow–up, and treatment activities with parents, caregivers, and health care providers; and            (iii)    Establishing fees for newborn screening that do not exceed an amount sufficient to cover the administrative, laboratory, and follow–up costs associated with the performance of screening tests under this subtitle.    (e)    Notwithstanding any other provision of law, if the Secretary of Health and Human Services issues federal recommendations on critical congenital heart disease screening of newborns, the Department shall adopt the federal screening recommendations.    (f)    (1)    The Secretary shall pay all fees collected under the provisions of this subtitle to the Comptroller.        (2)    The Comptroller shall distribute the fees to the Newborn Screening Program Fund established under § 13–113 of this subtitle.